CRBP

CRBP

USD

Corbus Pharmaceuticals Holdings Inc. Common Stock

$11.250-0.880 (-7.255%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$12.130

High

$12.168

Low

$11.230

Volume

0.56M

Company Fundamentals

Market Cap

191.2M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.27M

Exchange

NCM

Currency

USD

52-Week Range

Low $4.64Current $11.250High $20.77

Related News

GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public

View more
Corbus Pharmaceuticals Announces Pricing of Public Offering
GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced that it plans to offer and sell shares

View more
Corbus Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025

View more
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025